Ground News

Don't Just Read the News, Understand It.

hcplive.com image

News from hcplive.com

See all of hcplive.com news coverage in one place. Discover how hcplive.com’s media bias informs their coverage and compare with thousands of other news outlets.

Ground News has come across 818 headlines reported on by hcplive.com during the past 3 months.

hcplive.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is hcplive.com credible or reliable? Our Factuality score answers both of those questions. When it comes to hcplive.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about hcplive.com

Where is hcplive.com located?hcplive.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top hcplive.com News

US FDA approves Gilead's twice-yearly injection for HIV prevention

HIV · United States

US FDA approves Gilead's twice-yearly injection for HIV prevention

67% Center coverage: 202 sources

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months. See the Story

FDA Approves Once-Monthly Hereditary Angioedema Drug

FDA · United States

FDA Approves Once-Monthly Hereditary Angioedema Drug

62% Center coverage: 32 sources

Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) attacks in adult and pediatric patients ages 12 years and older, CSL announced.See the Story

Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

Healthcare · United States

Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

55% Center coverage: 22 sources

(MedPage Today) -- The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study. Among over 19,000 matched...See the Story

Alcohol-Linked Liver Deaths Rising in Women and Young Adults

49% Center coverage: 16 sources

Alcohol-related liver disease deaths are increasing — and they’re rising faster in some groups, including women, young adults and Indigenous people, new research shows.Stanford · United States See the Story

RX Review: Clesrovimab, RSV Education, and Immunization Uptake

100% Right coverage: 1 sources

In this video, part 2 in a 3-part series, panelists discuss clesrovimab's recent approval and gaps in clinician education.Vaccines See the Story

Dysregulation of Complement Pathway May Increase Risk of AMD Progression

New research has associated complement factors from both the classical and terminal pathways with progression from intermediate to advanced age-related macular degeneration.Read Article

ADA 2025 Late-Breaking Trials Preview

An overview of 7 presentations included as late-breaking clinical trials at ADA 2025.Read Article

Medical Ethics Unpacked: Shifting Vaccine Regulation and Policy, with Jason Schwartz, PhD

Explore the ethical dilemmas of vaccine policy and public trust in health systems as experts discuss the impact of COVID-19 on immunization attitudes.Coronavirus · United States Read Article

Fecal Microbiota Transplantation Shows Promise for First-Line Primary C Diff Treatment

Phase 3 trial results show FMT was noninferior to standard-of-care vancomycin for patients with a first episode of C diff infection.United States · United States Read Article

Pitolisant Shows Benefit for IH in Phase 3 Open-Label Trial, with Bruce Corser, MD

At SLEEP 2025, Bruce Corser, MD, discussed promising open-label data on pitolisant’s impact on idiopathic hypersomnia symptoms with HCPLive.Maryland · Maryland Read Article

Risks of Capsular Tension Ring Implantation May Outweigh Vision Benefits

Despite the possibility for enhanced stability of IOL rotation and tilt, the potential for ACD increase and a resulting hyperopic refractive shift warrants caution.Read Article

Breaking News Topics Related to hcplive.com